Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387160111> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W4387160111 endingPage "e601" @default.
- W4387160111 startingPage "e600" @default.
- W4387160111 abstract "For locally advanced laryngeal cancer (LAL), the local recurrence rate remains 19-40% after radical surgery with postoperative radiotherapy alone or with concurrent chemoradiotherapy in patients with unfavorable prognostic factors. We evaluate local control and acute toxicity of intraoperative radiation therapy (IORT) as a tumor bed boost for locally advanced laryngeal cancer in this prospective phase 2 trial.This phase II clinical study in which a total of 63 LAL patients (T2N1-3/T3N0-3/T4N0-3) were selected and received IORT (T2: 8-10Gy, T3,4:12-15 Gy) as a tumor bed boost during radical surgery, then received external-beam radiation therapy (EBRT) at a total dose of 54-60Gy within 6 weeks after surgery, 5 times per week, 1.8-2Gy per time, 30 times in total. The median follow-up time was 20 months (7 -39 months). The primary outcome was the local control (LC) and 2 - year survival rate determined using the Kaplan-Meier method. This study is registered with ClinicalTrials.gov, NCT04278638.A total of 63 patients consented to participate in the study; 59 males and 4 females, median age was 61 years (40-81 years), 14 patients had supraglottic LAL, 44 patients had glottic LAL and 5 patients had subglottic LAL. 10 patients showed high differentiation and 44 patients showed moderate differentiation and 9 patients showed low differentiation with laryngeal squamous cell carcinoma. 3 patients were in T2N1-2 stage, 40 patients in T3N0-2 stage, and 20 patients in T4N0-2 stage, 48 patients received total laryngectomy and 15 patients received hemilaryngectomy; 16 patients were lymph node-positive and 1 patient developed vascular tumor thrombus after surgery. After surgery combined with IORT and EBRT, the 1- and 2- year LC rates were 98.2% and 93.1 %, respectively, 2-year overall survival rate was 97.4%. Pharyngeal fistula was observed in 1 patient (1. 6 %) and wound infection in 3 patients (4.8%). Radiation Therapy Oncology Group (RTOG) grade 3 pain and RTOG grade 4 dyspnea were noted in one patient (1.6%) and 2 patients (3.2 %), respectively.In summary, our prospective phase II trial proved that the addition of intraoperative radiotherapy as a tumor bed boost to postoperative radiotherapy provided local therapeutic benefit to patients with locally advanced laryngeal cancer. Our data support the safety of this combined therapy. Additional investigation is warranted to determine the role of intraoperative radiotherapy in the local treatment of locally advanced laryngeal cancer." @default.
- W4387160111 created "2023-09-30" @default.
- W4387160111 creator A5000515580 @default.
- W4387160111 creator A5003642180 @default.
- W4387160111 creator A5016679728 @default.
- W4387160111 creator A5017941291 @default.
- W4387160111 creator A5027475930 @default.
- W4387160111 creator A5040205022 @default.
- W4387160111 creator A5040398944 @default.
- W4387160111 creator A5048661723 @default.
- W4387160111 creator A5050465904 @default.
- W4387160111 creator A5056185090 @default.
- W4387160111 creator A5086830971 @default.
- W4387160111 date "2023-10-01" @default.
- W4387160111 modified "2023-10-17" @default.
- W4387160111 title "A Phase 2 Trial of Efficacy and Safety of Intraoperative Radiation Therapy for Locally Advanced Laryngocarcinoma" @default.
- W4387160111 doi "https://doi.org/10.1016/j.ijrobp.2023.06.1962" @default.
- W4387160111 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37785812" @default.
- W4387160111 hasPublicationYear "2023" @default.
- W4387160111 type Work @default.
- W4387160111 citedByCount "0" @default.
- W4387160111 crossrefType "journal-article" @default.
- W4387160111 hasAuthorship W4387160111A5000515580 @default.
- W4387160111 hasAuthorship W4387160111A5003642180 @default.
- W4387160111 hasAuthorship W4387160111A5016679728 @default.
- W4387160111 hasAuthorship W4387160111A5017941291 @default.
- W4387160111 hasAuthorship W4387160111A5027475930 @default.
- W4387160111 hasAuthorship W4387160111A5040205022 @default.
- W4387160111 hasAuthorship W4387160111A5040398944 @default.
- W4387160111 hasAuthorship W4387160111A5048661723 @default.
- W4387160111 hasAuthorship W4387160111A5050465904 @default.
- W4387160111 hasAuthorship W4387160111A5056185090 @default.
- W4387160111 hasAuthorship W4387160111A5086830971 @default.
- W4387160111 hasConcept C141071460 @default.
- W4387160111 hasConcept C146357865 @default.
- W4387160111 hasConcept C151730666 @default.
- W4387160111 hasConcept C2776694085 @default.
- W4387160111 hasConcept C2778424827 @default.
- W4387160111 hasConcept C2780091936 @default.
- W4387160111 hasConcept C2780474809 @default.
- W4387160111 hasConcept C2781157581 @default.
- W4387160111 hasConcept C3019894029 @default.
- W4387160111 hasConcept C31760486 @default.
- W4387160111 hasConcept C509974204 @default.
- W4387160111 hasConcept C71924100 @default.
- W4387160111 hasConcept C86803240 @default.
- W4387160111 hasConceptScore W4387160111C141071460 @default.
- W4387160111 hasConceptScore W4387160111C146357865 @default.
- W4387160111 hasConceptScore W4387160111C151730666 @default.
- W4387160111 hasConceptScore W4387160111C2776694085 @default.
- W4387160111 hasConceptScore W4387160111C2778424827 @default.
- W4387160111 hasConceptScore W4387160111C2780091936 @default.
- W4387160111 hasConceptScore W4387160111C2780474809 @default.
- W4387160111 hasConceptScore W4387160111C2781157581 @default.
- W4387160111 hasConceptScore W4387160111C3019894029 @default.
- W4387160111 hasConceptScore W4387160111C31760486 @default.
- W4387160111 hasConceptScore W4387160111C509974204 @default.
- W4387160111 hasConceptScore W4387160111C71924100 @default.
- W4387160111 hasConceptScore W4387160111C86803240 @default.
- W4387160111 hasIssue "2" @default.
- W4387160111 hasLocation W43871601111 @default.
- W4387160111 hasLocation W43871601112 @default.
- W4387160111 hasOpenAccess W4387160111 @default.
- W4387160111 hasPrimaryLocation W43871601111 @default.
- W4387160111 hasRelatedWork W174345966 @default.
- W4387160111 hasRelatedWork W2015322621 @default.
- W4387160111 hasRelatedWork W2023463542 @default.
- W4387160111 hasRelatedWork W2157789193 @default.
- W4387160111 hasRelatedWork W2326320382 @default.
- W4387160111 hasRelatedWork W2412349368 @default.
- W4387160111 hasRelatedWork W2416811784 @default.
- W4387160111 hasRelatedWork W3118315771 @default.
- W4387160111 hasRelatedWork W4312262230 @default.
- W4387160111 hasRelatedWork W56355576 @default.
- W4387160111 hasVolume "117" @default.
- W4387160111 isParatext "false" @default.
- W4387160111 isRetracted "false" @default.
- W4387160111 workType "article" @default.